RxDoctor Payments Data

Leslie Thomas, MD

Pediatrics · Oxford, NCNPI 1891132833

Payments from drug & device makers

$279in general payments, 2019–2025

Across 19 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$60
  • AstraZeneca$40
  • Sanofi-aventis U.S. LLC$31
  • Pfizer$28
  • Merck$27
  • Beckman Coulter, Inc.$21
  • plus $72 from 5 others

What the payments were for

  • Food & beverage$26495%
  • Education$155%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$279 in reported general payments places this provider in the 60th percentile of 1,818 pediatrics providers in North Carolina.

See all pediatrics providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,718
Medicare patients
43
Services billed
98

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide103$136,732
JardianceEmpagliflozin33$33,470
EliquisApixaban29$32,656
LinzessLinaclotide33$28,530
XareltoRivaroxaban30$26,228
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$23,332
MounjaroTirzepatide11$13,541
TrulicityDulaglutide13$10,821
Spiriva RespimatTiotropium Bromide14$7,366
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$2,966
Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm19$2,449
Omeprazole127$2,210
Albuterol Sulfate HfaAlbuterol Sulfate43$1,635
Potassium Chloride31$1,458
Atorvastatin Calcium224$1,376

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$60$136,732103 claims
PfizerEliquis$28$32,65629 claims
Johnson & JohnsonXarelto$16$26,22830 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,818 pediatrics providers in North Carolina.

Other pediatrics in Oxford

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →